v.norgaard
Submits third-party assay reports on material purchased directly. Based in Accra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.73%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042737 | Selank | GGPeps | GGPE-2603-J9708 | Janoshik | 2026-Q3 | 98.40 | 9.14 | 97.4 | Buyer-sourced | 0 | FAIL |
| AX-2026-041725 | CJC-1295 with DAC | QSC | QSC-2602-E9474 | Medutest | 2026-Q3 | 99.06 | 7.04 | 107.3 | Supplier-supplied | 2 | FAIL |
| AX-2026-043274 | Hexarelin | CPC | CPC-2511-F1491 | PeptideMeter | 2026-Q2 | 98.89 | 5.10 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020470 | BPC-157 | KP | KP-2511-M5346 | Janoshik | 2025-Q4 | 98.73 | 5.13 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019586 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | Janoshik | 2025-Q4 | 99.93 | 5.95 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020801 | PT-141 (Bremelanotide) | SGN | SGN-2505-A9617 | Janoshik | 2025-Q3 | 98.20 | 3.91 | 102.2 | Supplier-supplied | 1 | FAIL |
| AX-2025-020823 | Semaglutide | SGN | SGN-2410-D9857 | PeptideMeter | 2025-Q1 | 97.54 | 4.47 | — | Buyer-sourced | 2 | MARGINAL |